{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:22:23Z","timestamp":1788542543602,"version":"build-2803163510"},"reference-count":167,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.revmed.2022.08.005","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T23:27:12Z","timestamp":1662593232000},"page":"713-726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Infection de l\u2019adulte \u00e0 Parvovirus"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-995X","authenticated-orcid":false,"given":"R.","family":"Jacquot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gerfaud-Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Mekki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Billaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Jamilloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7898","key":"10.1016\/j.revmed.2022.08.005_bib0840","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(75)91074-0","article-title":"Parvovirus-like particles in human sera","volume":"1","author":"Cossart","year":"1975","journal-title":"Lancet"},{"issue":"8221","key":"10.1016\/j.revmed.2022.08.005_bib0845","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(81)91579-8","article-title":"Parvovirus infections and hypoplastic crisis in sickle-cell anaemia","volume":"1","author":"Pattison","year":"1981","journal-title":"Lancet"},{"issue":"8338","key":"10.1016\/j.revmed.2022.08.005_bib0850","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0140-6736(83)92152-9","article-title":"Human parvovirus, the cause of erythema infectiosum (fifth disease)?","volume":"1","author":"Anderson","year":"1983","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib0855","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00428-002-0732-8","article-title":"Parvovirus B19: a pathogen responsible for more than hematologic disorders","volume":"442","author":"B\u00fcltmann","year":"2003","journal-title":"Virchows Arch"},{"issue":"8584","key":"10.1016\/j.revmed.2022.08.005_bib0860","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(88)91331-1","article-title":"Human parvovirus B19 and hydrops fetalis","volume":"1","author":"Anderson","year":"1988","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.revmed.2022.08.005_bib0865","first-page":"162","article-title":"[Parvovirus B19 infection. New physiopathological approaches]","volume":"25","author":"Labau","year":"1996","journal-title":"Presse Med"},{"issue":"8426","key":"10.1016\/j.revmed.2022.08.005_bib0870","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0140-6736(85)91146-8","article-title":"Human parvovirus-associated arthritis: a clinical and laboratory description","volume":"1","author":"Reid","year":"1985","journal-title":"Lancet"},{"issue":"8426","key":"10.1016\/j.revmed.2022.08.005_bib0875","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(85)91145-6","article-title":"Human parvovirus arthropathy","volume":"1","author":"White","year":"1985","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.revmed.2022.08.005_bib0880","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.revmed.2004.02.026","article-title":"[Systemic manifestations of Parvovirus B19 infections]","volume":"25","author":"S\u00e8ve","year":"2004","journal-title":"Rev Med Interne"},{"issue":"3","key":"10.1016\/j.revmed.2022.08.005_bib0885","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<936::AID-IMMU936>3.0.CO;2-X","article-title":"Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties","volume":"28","author":"Lunardi","year":"1998","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.revmed.2022.08.005_bib0890","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1182\/blood-2003-05-1522","article-title":"Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry","volume":"102","author":"Weigel-Kelley","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.revmed.2022.08.005_bib0895","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jclinpath-2015-203455","article-title":"The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease","volume":"69","author":"Kerr","year":"2016","journal-title":"J Clin Pathol"},{"issue":"12","key":"10.1016\/j.revmed.2022.08.005_bib0900","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0248-8663(96)80811-3","article-title":"[Human parvovirus B19 infection. Update]","volume":"16","author":"Karmochkine","year":"1995","journal-title":"Rev Med Interne"},{"issue":"8","key":"10.1016\/j.revmed.2022.08.005_bib0905","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1017\/S0950268807009661","article-title":"Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection","volume":"136","author":"Mossong","year":"2008","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib0910","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1399-3062.2010.00546.x","article-title":"Severe transfusion-transmitted parvovirus B19 infection in a naive immunocompromised patient","volume":"13","author":"Brodin-Sartorius","year":"2011","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib0915","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2011.03.012","article-title":"False-negative serology in patients with acute parvovirus B19 infection","volume":"51","author":"Bredl","year":"2011","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib0920","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bjh.13421","article-title":"Spectrum of adult Parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice","volume":"170","author":"Wolfromm","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib0925","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tracli.2015.11.006","article-title":"Update of the human parvovirus B19 biology","volume":"23","author":"Servant-Delmas","year":"2016","journal-title":"Transfus Clin Biol"},{"issue":"8","key":"10.1016\/j.revmed.2022.08.005_bib0930","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1086\/444503","article-title":"Slow clearance of human parvovirus B19 viremia following acute infection","volume":"41","author":"Lindblom","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"8978","key":"10.1016\/j.revmed.2022.08.005_bib0935","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(95)91673-3","article-title":"Persistent infection of human parvovirus B19 in a normal subject","volume":"346","author":"Sasaki","year":"1995","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib0940","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/rheumatology\/40.2.152","article-title":"Human parvovirus B19 infection in patients with systemic lupus erythematosus","volume":"40","author":"Hsu","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.revmed.2022.08.005_bib0945","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.DMIH2-0008-2015","article-title":"Parvovirus B19","volume":"4","author":"Landry","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib0950","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/CMR.00040-16","article-title":"Human Parvoviruses","volume":"30","author":"Qiu","year":"2017","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1016\/j.revmed.2022.08.005_bib0955","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/ard.59.9.672","article-title":"Pathogenesis of human parvovirus B19 in rheumatic disease","volume":"59","author":"Kerr","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2022.08.005_bib0960","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virusres.2016.06.004","article-title":"Nonstructural protein (NS1) of human parvovirus B19 stimulates host innate immunity and blunts the exogenous type I interferon signaling in vitro","volume":"222","author":"Wu","year":"2016","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib0965","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/JVI.75.1.540-543.2001","article-title":"Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19","volume":"75","author":"Tolfvenstam","year":"2001","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.revmed.2022.08.005_bib0970","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0020343","article-title":"Prolonged activation of virus-specific CD8 + T cells after acute B19 infection","volume":"2","author":"Isa","year":"2005","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib0975","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jmv.20514","article-title":"Aberrant cellular immune responses in humans infected persistently with parvovirus B19","volume":"78","author":"Isa","year":"2006","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib0980","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/318819","article-title":"T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus b19","volume":"183","author":"Franssila","year":"2001","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.revmed.2022.08.005_bib0985","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1128\/jvi.70.10.7327-7330.1996","article-title":"Lymphoproliferative responses after infection with human parvovirus B19","volume":"70","author":"von Poblotzki","year":"1996","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib0990","first-page":"1227","article-title":"Parvoviral infection of endothelial cells and its possible role in vasculitis and autoimmune diseases","volume":"29","author":"Magro","year":"2002","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib0995","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaad.2014.02.044","article-title":"Different patterns of skin manifestations associated with parvovirus B19 primary infection in adults","volume":"71","author":"Mage","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib1000","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jaad.2014.07.063","article-title":"Exanthems associated with parvovirus B19 infection in adults","volume":"71","author":"Drago","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.revmed.2022.08.005_bib1005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcv.2011.08.004","article-title":"Parvovirus B19-associated purpuric-petechial eruption","volume":"52","author":"Hashimoto","year":"2011","journal-title":"J Clin Virol"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1010","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.amjmed.2019.10.021","article-title":"Parvovirus B19 infection with positive Rumpel-Leede sign","volume":"133","author":"Mizumoto","year":"2020","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1015","doi-asserted-by":"crossref","first-page":"adv00398","DOI":"10.2340\/00015555-3761","article-title":"Eruptive pseudoangiomatosis: clinicopathological report of 20 adult cases and a possible novel association with Parvovirus B19","volume":"101","author":"Maqsood","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.revmed.2022.08.005_bib1020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijid.2014.06.014","article-title":"Generalized edema associated with parvovirus B19 infection","volume":"29","author":"Vlaar","year":"2014","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1025","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1111\/1346-8138.15851","article-title":"Acute generalized exanthematous pustulosis associated with human parvovirus B19 infection in an adolescent","volume":"48","author":"Hayashi","year":"2021","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib1030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/DAD.0b013e3181ce5933","article-title":"A case of sweet syndrome with spleen and lymph node involvement preceded by parvovirus B19 infection, and a review of the literature on extracutaneous sweet syndrome","volume":"32","author":"Fortna","year":"2010","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1035","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archinte.1989.00390050111022","article-title":"Clinical manifestations of human parvovirus B19 in adults","volume":"149","author":"Woolf","year":"1989","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.revmed.2022.08.005_bib1040","first-page":"233","article-title":"[Rheumatic manifestations of parvovirus B19 infection]","volume":"24","author":"Wendling","year":"1995","journal-title":"Presse Med"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/ar2480","article-title":"Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations","volume":"10","author":"Vassilopoulos","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.revmed.2022.08.005_bib1050","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/acr.20576","article-title":"Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study","volume":"63","author":"Varache","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/asheducation-2016.1.51","article-title":"Pure red cell aplasia","volume":"2016","author":"Means","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1060","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM198707303170506","article-title":"Chronic bone marrow failure due to persistent B19 parvovirus infection","volume":"317","author":"Kurtzman","year":"1987","journal-title":"N Engl J Med"},{"issue":"8855","key":"10.1016\/j.revmed.2022.08.005_bib1065","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0140-6736(93)91145-C","article-title":"Human parvovirus infection in homozygous sickle cell disease","volume":"341","author":"Serjeant","year":"1993","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1070","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood.V67.5.1411.1411","article-title":"Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia","volume":"67","author":"Saarinen","year":"1986","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1075","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bjh.13997","article-title":"Human parvovirus B19-induced transient red cell aplasia in a patient with vitamin B12 deficiency","volume":"173","author":"Hashimoto","year":"2016","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.blre.2013.12.002","article-title":"Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection","volume":"28","author":"Tsitsikas","year":"2014","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.revmed.2022.08.005_bib1085","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/tme.12671","article-title":"Parvovirus B19 infection in sickle cell disease: an analysis from the Centers for Disease Control haemoglobinopathy blood surveillance project","volume":"30","author":"Majumdar","year":"2020","journal-title":"Transfus Med"},{"issue":"8632","key":"10.1016\/j.revmed.2022.08.005_bib1090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0140-6736(89)91290-7","article-title":"Parvovirus and idiopathic thrombocytopenic purpura","volume":"1","author":"Lefr\u00e8re","year":"1989","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.revmed.2022.08.005_bib1095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/rmv.1839","article-title":"A review of blood diseases and cytopenias associated with human parvovirus B19 infection","volume":"25","author":"Kerr","year":"2015","journal-title":"Rev Med Virol"},{"issue":"8802","key":"10.1016\/j.revmed.2022.08.005_bib1100","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0140-6736(92)90735-L","article-title":"Viral-associated haemophagocytosis with parvovirus-B19-related pancytopenia","volume":"339","author":"Muir","year":"1992","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.revmed.2022.08.005_bib1105","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/ccr3.2401","article-title":"Parvovirus B19-induced hemophagocytic lymphohistiocytosis: case report and review of the literature","volume":"7","author":"Kalmuk","year":"2019","journal-title":"Clin Case Rep"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5144\/0256-4947.59371","article-title":"Reactive macrophage activation syndrome in a patient with parvovirus B19 infection, lymphocytic lichenoid vasculitis, urticaria and angioedema","volume":"30","author":"Soldo-Juresa","year":"2010","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.revmed.2022.08.005_bib1115","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-213492","article-title":"Parvovirus leading to thrombotic microangiopathy in a healthy adult","volume":"2016","author":"Prasad","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib1120","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1681\/ASN.V1161132","article-title":"Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation","volume":"11","author":"Murer","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12879-018-3227-1","article-title":"Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults","volume":"18","author":"Dollat","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.revmed.2022.08.005_bib1130","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1128\/JCM.00575-11","article-title":"Acute hepatitis as a manifestation of parvovirus B19 infection","volume":"49","author":"Hatakka","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.revmed.2022.08.005_bib1135","first-page":"472027","article-title":"Parvovirus b19 associated hepatitis","volume":"2013","author":"Bihari","year":"2013","journal-title":"Hepat Res Treat"},{"key":"10.1016\/j.revmed.2022.08.005_bib1140","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2334-10-246","article-title":"Chronic hepatitis caused by persistent parvovirus B19 infection","volume":"10","author":"Mogensen","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.revmed.2022.08.005_bib1145","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1086\/599042","article-title":"Neurologic manifestations associated with parvovirus B19 infection","volume":"48","author":"Douvoyiannis","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.revmed.2022.08.005_bib1150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/rmv.1782","article-title":"Neurological aspects of human parvovirus B19 infection: a systematic review","volume":"24","author":"Barah","year":"2014","journal-title":"Rev Med Virol"},{"issue":"S1","key":"10.1016\/j.revmed.2022.08.005_bib1155","first-page":"e2021129","article-title":"A Parsonage-Turner syndrome secondary to Parvovirus B19 infection","volume":"92","author":"Mozzani","year":"2021","journal-title":"Acta Biomed"},{"issue":"8","key":"10.1016\/j.revmed.2022.08.005_bib1160","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00415-011-5949-5","article-title":"Parvovirus B19 infection antedating Guillain-Barre\u2019 syndrome variant with prominent facial diplegia","volume":"258","author":"Barbi","year":"2011","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.revmed.2022.08.005_bib1165","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00415-011-5931-2","article-title":"Mononeuropathy multiplex associated with acute parvovirus B19 infection: characteristics, treatment and outcome","volume":"258","author":"Lenglet","year":"2011","journal-title":"J Neurol"},{"issue":"8","key":"10.1016\/j.revmed.2022.08.005_bib1170","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00415-011-5949-5","article-title":"Parvovirus B19 infection antedating Guillain-Barre\u2019 syndrome variant with prominent facial diplegia","volume":"258","author":"Barbi","year":"2011","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.revmed.2022.08.005_bib1175","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0248-8663(00)88934-1","article-title":"[Primary parvovirus B19 infection in immunocompetent adults: clinical and biological manifestations. Retrospective study of 16 patients]","volume":"21","author":"Cath\u00e9bras","year":"2000","journal-title":"Rev Med Interne"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.braindev.2010.03.003","article-title":"Acute autonomic sensory and motor neuropathy associated with parvovirus B19 infection","volume":"33","author":"Hanai","year":"2011","journal-title":"Brain Dev"},{"key":"10.1016\/j.revmed.2022.08.005_bib1185","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.2215\/CJN.01060307","article-title":"Parvovirus B19 and the kidney","volume":"2 Suppl. 1","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8973","key":"10.1016\/j.revmed.2022.08.005_bib1190","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(95)91324-6","article-title":"Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease","volume":"346","author":"Wierenga","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.revmed.2022.08.005_bib1195","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/08860221003728713","article-title":"Parvovirus B19-induced multisystemic vasculitis and acute endocapillary proliferative glomerulonephritis in a child","volume":"32","author":"Sakalli","year":"2010","journal-title":"Ren Fail"},{"issue":"7","key":"10.1016\/j.revmed.2022.08.005_bib1200","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3109\/0886022X.2010.494791","article-title":"Endocapillary glomerulonephritis secondary to human parvovirus B19 presenting with nephrotic syndrome: a report of two cases and a review of the literature","volume":"32","author":"Abeygunasekara","year":"2010","journal-title":"Ren Fail"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CNP57069","article-title":"Association of parvovirus B19 infection with acute glomerulonephritis in healthy adults: case report and review of the literature","volume":"57","author":"Mori","year":"2002","journal-title":"Clin Nephrol"},{"issue":"6\u20137","key":"10.1016\/j.revmed.2022.08.005_bib1210","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.acvd.2009.04.010","article-title":"Viral causes of human myocarditis","volume":"102","author":"Andr\u00e9oletti","year":"2009","journal-title":"Arch Cardiovasc Dis"},{"issue":"13","key":"10.1016\/j.revmed.2022.08.005_bib1215","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMc0911362","article-title":"Human parvovirus B19-associated myocarditis","volume":"362","author":"Bock","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.revmed.2022.08.005_bib1220","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/ejhf.665","article-title":"Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature","volume":"18","author":"Verdonschot","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.revmed.2022.08.005_bib1225","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1086\/648074","article-title":"Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis","volume":"49","author":"Kuethe","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.revmed.2022.08.005_bib1230","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1128\/JCM.00580-09","article-title":"Pathophysiological mechanisms of parvovirus B19 infection","volume":"47","author":"Noutsias","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.revmed.2022.08.005_bib1235","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1002\/ehf2.13341","article-title":"Parvovirus B19 DNA detectable in hearts of patients with dilated cardiomyopathy, but absent or inactive in blood","volume":"8","author":"Russcher","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib1240","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1016\/j.amjmed.2019.11.012","article-title":"A case of subacute thyroiditis associated with erythrovirus B19 infection","volume":"133","author":"Chiaruzzi","year":"2020","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1245","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.eimc.2020.04.002","article-title":"Anterior bilateral uveitis and acute parvovirus B19 infection","volume":"39","author":"Arias-Peso","year":"2021","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1250","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0369-8114(02)00302-4","article-title":"Antibody responses in parvovirus B19 infected patients","volume":"50","author":"Modrow","year":"2002","journal-title":"Pathol Biol (Paris)"},{"issue":"3","key":"10.1016\/j.revmed.2022.08.005_bib1255","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1128\/CVI.00380-08","article-title":"Acute parvovirus B19 infection frequently causes false-positive results in Epstein-Barr virus- and herpes simplex virus-specific immunoglobulin M determinations done on the Liaison platform","volume":"16","author":"Berth","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1260","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.revmed.2013.04.015","article-title":"Manifestations cliniques et biologiques de la primo-infection \u00e0 parvovirus B19 chez l\u2019adulte immunocomp\u00e9tent\u00a0: \u00e9tude r\u00e9trospective de 26 observations","volume":"35","author":"Parra","year":"2014","journal-title":"Rev Med Interne"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0163-4453(96)80008-9","article-title":"Autoantibodies following parvovirus B19 infection","volume":"32","author":"Kerr","year":"1996","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib1270","first-page":"777","article-title":"Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19","volume":"16","author":"Soloninka","year":"1989","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1275","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/art.1780400115","article-title":"Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus","volume":"40","author":"Loizou","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1280","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.autrev.2008.07.005","article-title":"Human parvovirus B19 infection and autoimmunity","volume":"8","author":"Lunardi","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.revmed.2022.08.005_bib1285","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/JVI.76.4.2014-2018.2002","article-title":"The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity","volume":"76","author":"Dorsch","year":"2002","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1290","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jmv.2217","article-title":"Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections?","volume":"67","author":"Mitchell","year":"2002","journal-title":"J Med Virol"},{"issue":"8895","key":"10.1016\/j.revmed.2022.08.005_bib1295","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(94)92725-1","article-title":"Parvovirus B19 and erosive polyarthritis","volume":"343","author":"Tyndall","year":"1994","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.revmed.2022.08.005_bib1300","first-page":"1265","article-title":"Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis","volume":"35","author":"Kozireva","year":"2008","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.revmed.2022.08.005_bib1305","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1099\/jgv.0.000621","article-title":"Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis","volume":"97","author":"Naciute","year":"2016","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1310","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/v13020277","article-title":"Viral infections and systemic lupus erythematosus: new players in an old story","volume":"13","author":"Quaglia","year":"2021","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.revmed.2022.08.005_bib1315","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.semarthrit.2004.07.008","article-title":"Lupus-like presentation of parvovirus B19 infection","volume":"34","author":"S\u00e8ve","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.revmed.2022.08.005_bib1320","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/ard.61.7.662","article-title":"Self limiting lupus-like symptoms in patients with parvovirus B19 infection","volume":"61","author":"T\u00f3v\u00e1ri","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.revmed.2022.08.005_bib1325","first-page":"2335","article-title":"Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection","volume":"28","author":"Kalt","year":"2001","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.revmed.2022.08.005_bib1330","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0002-9343(01)00904-4","article-title":"Lupus-like presentation of parvovirus B19 infection","volume":"111","author":"Narv\u00e1ez Garcia","year":"2001","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1335","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0049-0172(99)80016-X","article-title":"Human parvovirus B19 infection: its relationship with systemic lupus erythematosus","volume":"28","author":"Trapani","year":"1999","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib1340","first-page":"1165","article-title":"Chronic modulation of the autoimmune response following parvovirus B19 infection","volume":"21","author":"Vigeant","year":"1994","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1345","first-page":"169","article-title":"Lupus-like presentation of human parvovirus B19 infection","volume":"19","author":"Kalish","year":"1992","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1350","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0049-0172(95)80001-8","article-title":"Parvovirus infection mimicking systemic lupus erythematosus","volume":"24","author":"Nesher","year":"1995","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.revmed.2022.08.005_bib1355","first-page":"1180","article-title":"Human parvovirus infection: rheumatic manifestations, angioedema, C1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus","volume":"23","author":"Fawaz-Estrup","year":"1996","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1360","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1198-743x.2001.00361.x","article-title":"Systemic lupus erythematosus associated with acute parvovirus B19 infection","volume":"8","author":"D\u00edaz","year":"2002","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib1365","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/ard.51.6.803","article-title":"Possible induction of systemic lupus erythematosus by human parvovirus","volume":"51","author":"Cope","year":"1992","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1370","first-page":"968","article-title":"Postpartum lupus erythematosus associated with parvovirus B19 infection","volume":"24","author":"Nigro","year":"1997","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.revmed.2022.08.005_bib1375","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/03009749509099309","article-title":"The variable clinical picture of arthritis induced by human parvovirus B19. Report of seven adult cases and review of the literature","volume":"24","author":"Gran","year":"1995","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1380","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1386-6532(99)00038-4","article-title":"Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient","volume":"14","author":"Hemauer","year":"1999","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1385","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/096120339100100107","article-title":"Parvovirus B19 infection can induce histiocytic necrotizing lymphadenitis (Kikuchi's disease) associated with systemic lupus erythematosus","volume":"1","author":"Meyer","year":"1991","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1390","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10067-007-0691-1","article-title":"Emerging lupus-like manifestations in acute parvovirus B19 infection","volume":"27","author":"Sugimoto","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib1395","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MD.0b013e31818ec711","article-title":"Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.revmed.2022.08.005_bib1400","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/art.11038","article-title":"Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection","volume":"48","author":"Von Landenberg","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1405","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.59.1.64","article-title":"No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19","volume":"59","author":"Bengtsson","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib1410","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3899\/jrheum.101332","article-title":"Association of parvovirus B19 infection with systemic lupus erythematosus: role of Th1 predominance","volume":"38","author":"Park","year":"2011","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.revmed.2022.08.005_bib1415","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.3899\/jrheum.100345","article-title":"Parvovirus B19-associated systemic lupus erythematosus: clinical mimicry or autoimmune induction?","volume":"37","author":"Hession","year":"2010","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1420","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/21505594.2017.1385691","article-title":"Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome","volume":"9","author":"Lin","year":"2018","journal-title":"Virulence"},{"issue":"14","key":"10.1016\/j.revmed.2022.08.005_bib1425","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1177\/0961203316640912","article-title":"Systematic review of case reports of antiphospholipid syndrome following infection","volume":"25","author":"Abdel-Wahab","year":"2016","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.revmed.2022.08.005_bib1430","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1034\/j.1600-0560.2000.027010505.x","article-title":"A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes","volume":"27","author":"Crowson","year":"2000","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1435","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/clinids\/21.2.430","article-title":"Juvenile dermatomyositis in a child infected with human parvovirus B19","volume":"21","author":"Lewkonia","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.revmed.2022.08.005_bib1440","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/rheumatology\/39.9.1037","article-title":"Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle","volume":"39","author":"Chevrel","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1445","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/rheumatology\/keg085","article-title":"Lack of evidence for a direct involvement of muscle infection by parvovirus B19 in the pathogenesis of inflammatory myopathies: a follow-up study","volume":"42","author":"Chevrel","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"17","key":"10.1016\/j.revmed.2022.08.005_bib1450","first-page":"2170","article-title":"Parvovirus B19 and onset of juvenile dermatomyositis","volume":"294","author":"Mamyrova","year":"2005","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.revmed.2022.08.005_bib1455","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/ard.61.9.855","article-title":"Absence of human parvovirus B19 DNA in myoepithelial sialadenitis of primary Sj\u00f6gren's syndrome","volume":"61","author":"De Re","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib1460","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/sarh.2000.7024","article-title":"Cytopenia and past human parvovirus B19 infection in patients with primary Sj\u00f6gren's syndrome","volume":"29","author":"Ramos-Casals","year":"2000","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1465","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/ard.62.1.86","article-title":"No association between human parvovirus B19 infection and Sj\u00f6gren's syndrome","volume":"62","author":"De Stefano","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib1470","first-page":"718","article-title":"Parvovirus B19 infection of bone marrow in systemic sclerosis patients","volume":"17","author":"Ferri","year":"1999","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.revmed.2022.08.005_bib1475","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/art.10346","article-title":"Parvovirus B19 infection of cultured skin fibroblasts from systemic sclerosis patients: comment on the article by Ray et al","volume":"46","author":"Ferri","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1480","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.0303-6987.2003.0143.x","article-title":"Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma","volume":"31","author":"Magro","year":"2004","journal-title":"J Cutan Pathol"},{"issue":"11","key":"10.1016\/j.revmed.2022.08.005_bib1485","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/art.1780371122","article-title":"Wegener's granulomatosis and parvovirus B19 infection","volume":"37","author":"Nikkari","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.revmed.2022.08.005_bib1490","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/art.1780380826","article-title":"Association of Wegener's granulomatosis with parvovirus B19 infection: comment on the concise communication by Nikkari et al","volume":"38","author":"Corman","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"8791","key":"10.1016\/j.revmed.2022.08.005_bib1495","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0140-6736(92)91096-Q","article-title":"Polyarteritis nodosa and parvovirus B19 infection","volume":"339","author":"Corman","year":"1992","journal-title":"Lancet"},{"issue":"8908","key":"10.1016\/j.revmed.2022.08.005_bib1500","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(94)92152-0","article-title":"Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?","volume":"343","author":"Finkel","year":"1994","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.revmed.2022.08.005_bib1505","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJM200105103441919","article-title":"Treatment of parvovirus B19-associated polyarteritis nodosa with intravenous immune globulin","volume":"344","author":"Viguier","year":"2001","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1510","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0248-8663(05)81309-8","article-title":"[Periarteritis nodosa and parvovirus B19 infection]","volume":"14","author":"Gaches","year":"1993","journal-title":"Rev Med Interne"},{"issue":"10","key":"10.1016\/j.revmed.2022.08.005_bib1515","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/rheumatology\/41.10.1210","article-title":"Parvovirus B19 infection associated with myelosuppression and cutaneous polyarteritis nodosa","volume":"41","author":"Durst","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"8917","key":"10.1016\/j.revmed.2022.08.005_bib1520","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(94)93030-9","article-title":"Polyarteritis nodosa and parvovirus B19","volume":"344","author":"Leruez-Ville","year":"1994","journal-title":"Lancet"},{"issue":"8457","key":"10.1016\/j.revmed.2022.08.005_bib1525","first-page":"730","article-title":"Human parvovirus and purpura","volume":"2","year":"1985","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1530","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1542\/peds.78.1.183a","article-title":"Henoch-Sch\u00f6nlein purpura and human parvovirus infection","volume":"78","author":"Lefr\u00e8re","year":"1986","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.revmed.2022.08.005_bib1535","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF01644022","article-title":"Human parvovirus B19 infection associated with vascular purpura and vasculitis","volume":"17","author":"Schwarz","year":"1989","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1540","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1442-200x.2000.01161.x","article-title":"Henoch-Sch\u00f6nlein purpura nephritis associated with human parvovirus B19 infection","volume":"42","author":"Watanabe","year":"2000","journal-title":"Pediatr Int"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1545","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0248-8663(01)00516-1","article-title":"[Rheumatoid purpura in adults and parvovirus B19 infection: fortuitous association or parvovirus B19-induced vasculitis?]","volume":"23","author":"Qu\u00e9m\u00e9neur","year":"2002","journal-title":"Rev Med Interne"},{"issue":"10","key":"10.1016\/j.revmed.2022.08.005_bib1550","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1034\/j.1600-0560.2002.291006.x","article-title":"Parvovirus B19 associated adult Henoch Sch\u00f6nlein purpura","volume":"29","author":"Cioc","year":"2002","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1555","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000246839","article-title":"Henoch-Sch\u00f6nlein purpura and human parvovirus B19","volume":"189","author":"Veraldi","year":"1994","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1560","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/art.1780390523","article-title":"Prevalence of human parvovirus B19 infection in children with Henoch-Sch\u00f6nlein purpura","volume":"39","author":"Ferguson","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1565","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000045499","article-title":"Parvovirus B19 and Sch\u00f6nlein-Henoch purpura in adults","volume":"83","author":"Challine-Lehmann","year":"1999","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.revmed.2022.08.005_bib1570","first-page":"175","article-title":"[Vasculitis with mixed cryoglobulin in human parvovirus B19 infection]","volume":"22","author":"Delannoy","year":"1993","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2022.08.005_bib1575","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2015.08.008","article-title":"Non-HCV-related infectious cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey and systematic review of the literature","volume":"65","author":"Terrier","year":"2015","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.005_bib1580","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jbspin.2016.12.013","article-title":"Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection","volume":"85","author":"Lazzerini","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib1585","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/clinids\/22.6.1123","article-title":"Association of parvovirus B19 infection with giant cell arteritis","volume":"22","author":"Staud","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.005_bib1590","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO;2-P","article-title":"The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation","volume":"42","author":"Gabriel","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.revmed.2022.08.005_bib1595","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1002\/art.10580","article-title":"Detection of parvovirus B19 DNA by polymerase chain reaction in giant cell arteritis: a case-control study","volume":"46","author":"Salvarani","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1600","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2230.2006.02330.x","article-title":"Detection of parvovirus B19 DNA in the lesional skin of patients with Beh\u00e7et's disease","volume":"32","author":"Baskan","year":"2007","journal-title":"Clin Exp Dermatol"},{"issue":"8908","key":"10.1016\/j.revmed.2022.08.005_bib1605","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(94)92154-7","article-title":"Active or recent parvovirus B19 infection in children with Kawasaki disease","volume":"343","author":"Nigro","year":"1994","journal-title":"Lancet"},{"issue":"8914","key":"10.1016\/j.revmed.2022.08.005_bib1610","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0140-6736(94)91080-4","article-title":"Human parvovirus B19 infection in Kawasaki disease","volume":"344","author":"Yoto","year":"1994","journal-title":"Lancet"},{"issue":"8914","key":"10.1016\/j.revmed.2022.08.005_bib1615","first-page":"59","article-title":"Human parvovirus B19 infection in Kawasaki disease","volume":"344","author":"Cohen","year":"1994","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.revmed.2022.08.005_bib1620","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/cid\/cis1046","article-title":"Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature","volume":"56","author":"Crabol","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.revmed.2022.08.005_bib1625","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7326\/0003-4819-113-12-926","article-title":"Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS","volume":"113","author":"Frickhofen","year":"1990","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1630","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7861\/clinmedicine.16-2-129","article-title":"Viral arthritis","volume":"16","author":"Marks","year":"2016","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"10.1016\/j.revmed.2022.08.005_bib1635","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4149\/av_2014_03_199","article-title":"Human parvovirus B19: a review","volume":"58","author":"Rogo","year":"2014","journal-title":"Acta Virol"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.005_bib1640","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ejhf.2082","article-title":"Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double-blind, randomized, placebo-controlled clinical trial","volume":"23","author":"Hazebroek","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.revmed.2022.08.005_bib1645","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cardfail.2009.12.016","article-title":"Interferon beta-1b therapy in chronic viral dilated cardiomyopathy\u00a0\u2013\u00a0is there a role for specific therapy?","volume":"16","author":"Zimmermann","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.revmed.2022.08.005_bib1650","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.antiviral.2014.11.004","article-title":"Antiviral effect of cidofovir on parvovirus B19 replication","volume":"113","author":"Bonvicini","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.revmed.2022.08.005_bib1655","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.antiviral.2018.12.003","article-title":"Antiviral activity of brincidofovir on parvovirus B19","volume":"162","author":"Bua","year":"2019","journal-title":"Antiviral Res"},{"issue":"7","key":"10.1016\/j.revmed.2022.08.005_bib1660","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.3390\/v11070659","article-title":"Advances in the development of antiviral strategies against Parvovirus B19","volume":"11","author":"Manaresi","year":"2019","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.005_bib1665","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/167.5.1034","article-title":"Candidate recombinant vaccine for human B19 parvovirus","volume":"167","author":"Bansal","year":"1993","journal-title":"J Infect Dis"},{"issue":"43","key":"10.1016\/j.revmed.2022.08.005_bib0835","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1016\/j.vaccine.2011.07.080","article-title":"Safety and immunogenicity of a candidate parvovirus B19 vaccine","volume":"29","author":"Bernstein","year":"2011","journal-title":"Vaccine"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322006099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322006099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:45:47Z","timestamp":1759337147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866322006099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":167,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0248866322006099"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2022.08.005","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infection de l\u2019adulte \u00e0 Parvovirus","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2022.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}